July 2025 in “Annals of Medicine” This study describes a planned multicenter randomized controlled trial to assess the safety, tolerability, and pharmacokinetics of subdermal gestrinone pellets in patients with deep infiltrative endometriosis-related pelvic pain, but it does not report any findings yet.
November 2023 in “Journal of Drugs in Dermatology” In this study, stabilized super-oxidized hypochlorous acid was used during and after hair transplant surgeries, reportedly reducing erythema and pruritus in over half of patients, with high compliance and no tissue necrosis observed.
This review found that evidence supporting Moringa oleifera's skin and hair benefits in rinse-off products is limited and would benefit from more direct trials on finished product formats.
1 citations
,
February 2022 in “Journal of the American Academy of Dermatology” This article outlines how patient safety is integrated into the healthcare system, focusing on quality improvement and processes such as error reporting and root cause analysis, specifically for dermatologists.
3 citations
,
May 2018 in “Journal of the Egyptian Womenʼs Dermatologic Society” This study found that platelet-rich plasma treatment was effective and safe for promoting hair regrowth in mild cases of alopecia areata, with significant improvements in quality of life compared to placebo.
This study found that DR SKS Hair Growth Booster Serum significantly reduced hair fall and improved hair density in patients with androgenic alopecia over six months, with high patient satisfaction and no major adverse events reported.
November 2024 in “Journal of Investigative Dermatology” Microfluidic models improve testing for aging, wound healing, and oral tissue, reducing animal testing.
1 citations
,
January 2017 in “Springer eBooks” This chapter reviews the hair follicle's role in drug and chemical penetration through the skin but does not present new experimental findings.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This policy brief found that post-drug syndromes are under-recognized in current pharmacovigilance systems, leading to inadequate risk assessments and prolonged patient harm from persistent drug-induced conditions.
This review article highlights the potential of various herbal treatments, such as Saw Palmetto and Ginseng, in promoting hair growth and managing alopecia, while emphasizing the necessity for more rigorous clinical trials.
1 citations
,
November 2018 in “Dermatologic Therapy” This report describes the use of compounded topical preparations to treat two severe psoriasis patients and calls for further studies on their regulation, protocol, and stability evaluation.
In this study, researchers developed a standardized Ayurvedic hair pack using natural ingredients like Shikakai and Amla and confirmed its safety and pH suitability; they concluded it could be a scientifically validated alternative to synthetic hair products.
In this study, low-dose oral minoxidil was found to have a favorable safety profile for treating alopecia, with mostly mild side effects, in both general and hypertensive populations.
April 2026 in “Pharmaceutics” This review highlights cellulose-based materials' potential in skin disease treatments, emphasizing their smart, responsive design for various conditions, with insights into their roles in wound healing, infection prevention, and wearable monitoring.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reviewed the properties and safety of henna as a hair dye and found it to be safer than synthetic dyes but with limitations in color range and stability.
3 citations
,
September 2022 in “Archives of dermatological research” In this study, fractional CO2 laser treatment for alopecia areata was found to significantly increase terminal hair and patient satisfaction compared to betamethasone valerate cream alone, highlighting its efficacy and safety both as a standalone and combined treatment.
January 2014 in “Anales Médicos de la Asociación Médica del Centro Médico ABC” This study suggests that a combination of topical minoxidil with oral finasteride and dutasteride may promote new hair growth in androgenetic alopecia, with minor safety concerns reported.
December 2023 in “International Journal of Newgen Research in Pharmacy & Healthcare” This study evaluated the physicochemical characteristics, safety, and efficacy of six herbal and six synthetic shampoos and found that all products performed well in various tests, with no skin irritancy observed, suggesting that both types can be considered safe for use.
3 citations
,
July 2024 in “Journal of the American Academy of Dermatology” Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.
December 2023 in “International Journal of Advanced Research in Science, Communication and Technology” This study evaluated an herbal shampoo's physicochemical properties and emphasized its safety, efficacy, and quality as a non-toxic natural hair care product.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that the methanol leaf extract of Ficus platyphylla demonstrated a high margin of acute safety in Wistar rats, showing minimal risk under short-term exposure with no mortality at doses up to 5000 mg/kg and no significant changes in liver enzyme activities.
75 citations
,
August 2006 in “International Journal of Pharmaceutics” The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.
2 citations
,
October 2025 in “Frontiers in Medicine” This study found that deuruxolitinib may effectively improve hair regrowth and patient satisfaction in moderate to severe alopecia areata, but careful monitoring is needed due to manageable side effects and concerns about long-term safety.
June 2026 in “Aesthetic Cosmetology and Medicine” This study reported that patients with mild to detectable androgenetic alopecia showed subjective improvement and a favorable safety profile after receiving a polynucleotide-based intradermal gel, with only one case of mild injection-site erythema noted among 60 participants over three months.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review summarizes current research on natural hair dyes, reporting that plant-based formulations can safely provide viable colors on gray hair with minimal irritation compared to synthetic options but face challenges in color range and consistency.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study formulated a herbal anti-dandruff shampoo using natural ingredients, which showed desirable characteristics such as satisfactory foam stability and effective cleansing ability, comparable to standard formulations; however, further studies are recommended to assess its long-term safety.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reported that the formulated herbal anti-dandruff shampoo demonstrated satisfactory cleansing and conditioning properties, comparable to standard synthetic shampoos, but further testing is needed to confirm its long-term safety.
May 2025 in “EPRA International Journal of Research & Development (IJRD)” This study aimed to formulate and evaluate an herbal anti-dandruff shampoo using natural ingredients, prioritizing safety and efficacy to minimize side effects commonly associated with synthetic shampoos.
2 citations
,
February 2019 in “PubMed” In this study, Biofibre® artificial hair implantation showed high patient satisfaction and low fiber loss over three years among those with androgenetic alopecia, suggesting its safety and effectiveness for both genders with limited donor supply or needing quick results.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study tested the acute toxicity of Ficus platyphylla methanol leaf extract in Wistar rats and found no mortality or significant liver enzyme changes at doses up to 5000 mg/kg, suggesting a high margin of acute safety and supporting its traditional use under short-term exposure.